UNDERVALUEDNASDAQ · Healthcare

Shuttle Pharmaceuticals, Inc.

SHPH

FAIR PRICE VALUATION

46.0%upside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$0.69

FAIR PRICE

$1.00

MARGIN

$0.31

UNDERVALUEDFAIROVERVALUED

P/E Ratio

N/A

Div. Yield

N/A

ROE

-476.1%

Average

Market Cap

$726840

Small-cap

COMING SOON

Get notified when SHPH's fair price changes

Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.

iOS and Android · Free tier available

KEY FACTS

CEO

Christopher Robert Cooper

COUNTRY

US

HEADQUARTERS

Gaithersburg

SECTOR

Healthcare

EXCHANGE

NASDAQ

METHODOLOGY

How we calculate SHPH's fair price

Shuttle Pharmaceuticals, Inc.'s fair price of $1.00 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $0.69, SHPH trades 46.0% below its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting SHPH's risk profile.

RELATIVE · 30%

Comparing SHPH's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for SHPH, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate SHPH's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for SHPH.

Explore on Bulios

FAQ

What is the fair price of SHPH?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Shuttle Pharmaceuticals, Inc. is $1.00. At the current market price of $0.69, SHPH trades 46.0% below its calculated fair value.

Is SHPH overvalued or undervalued?+

Shuttle Pharmaceuticals, Inc. is currently undervalued based on our valuation model. The stock trades at $0.69, which is 46.0% below the fair price of $1.00.

How often is SHPH's fair price updated?+

We update fair price calculations for SHPH daily after market close. The current fair price of $1.00 incorporates the latest market data and sector multiples.

What factors affect SHPH's fair price calculation?+

SHPH's fair price of $1.00 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -476.1%.

Is SHPH a good buy right now?+

At $0.69, SHPH trades 46.0% below our fair value estimate of $1.00. The stock is currently undervalued. ROE stands at -476.1% (average). Fair Price Index provides valuation data — always do your own research before investing.

Does SHPH pay dividends?+

SHPH does not currently pay a dividend.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.